Worried About the Flu Season?
Volunteer in Influenza mRNA Vaccine Clinical Trials and Help Advance Future Flu Prevention Research
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Each year, seasonal flu infects millions of people worldwide, leading to significant hospitalizations and deaths, especially among older adults, young children, and individuals with weakened immune systems.
Traditional flu vaccines are developed using egg-based or cell-based methods, which require months of production. However, mRNA technology successfully used during the COVID-19 pandemic offers a faster, more adaptable approach to flu prevention. mRNA vaccines teach the immune system to recognize influenza proteins, enabling a stronger and potentially longer-lasting immune response.
To better understand the safety and effectiveness of these vaccines, Revival Research Institute is conducting Influenza mRNA Vaccine Clinical Trials.
Who Can Participate?
You may be eligible for the Influenza mRNA Vaccine Clinical Trials if you are:
- Male or female participant at least 65 years of age at the time of the study
- Written or witnessed (physically or digitally) informed consent obtained
*Additional criteria may apply.
Participation includes access to study-related medical care, investigational influenza vaccine, health monitoring, and regular monitoring, with no insurance required.
About Influenza mRNA Vaccine Clinical Trials
At Revival Research Institute, we are conducting clinical trials for evaluating investigational mRNA-based influenza vaccines. These trials are designed to study the safety and effectiveness of investigational vaccines being evaluated for the prevention of seasonal influenza. Our studies are carried out under strict ethical and regulatory guidelines, with the goal of offering innovative options for flu prevention.
If you qualify, you may have the opportunity to receive an investigational flu vaccine at no cost.
*All study procedures and investigational vaccines are provided free of charge, and no insurance is required.
*Participating in the Influenza mRNA Vaccine Clinical Trials is completely voluntary. You can discontinue or stop taking part at any time. There will be other study requirements the study team will discuss with you if you participate in this study.
Get Started
What to Expect?
If you meet the study requirements, you may be eligible to participate in a clinical trial evaluating an investigational influenza mRNA vaccine. After you fill out the interest form above, someone from our research team will contact you for a short pre-screening to see if you meet the basic requirements.
If you qualify, we will ask you to review and sign an Informed Consent Form (ICF), which explains the study, including what’s involved, possible benefits, and risks.
After giving your consent, you will be invited to a screening visit at one of our clinical research sites. During this visit, we will go over your medical history, do a physical exam, and run some lab tests to confirm eligibility.
Our research team will guide you through every step and make sure you fully understand what participation involves. You will have the chance to ask any questions before deciding to join. By taking part, you are helping advance research that could improve future treatment for Influenza.
Age
18 years or older
Condition
Influenza Prevention (mRNA Vaccine Trial)
Location
The Importance of Influenza mRNA Vaccine Clinical Trials
Influenza remains a major public health challenge, with seasonal epidemics causing up to 650,000 respiratory-related deaths globally each year (World Health Organization). Current flu vaccines vary in effectiveness, typically ranging from 40%–60%, depending on the season and circulating strains.
mRNA vaccine technology could change the future of flu prevention. Unlike traditional vaccines, which take months to manufacture, mRNA flu vaccines can be updated rapidly to match evolving strains. They may also offer broader protection against multiple influenza variants.
By joining these clinical trials at Revival Research Institute, you are not only gaining access to innovative care but also contributing to research that could benefit millions worldwide.
Influenza Risk Factors
- Older adults (65+)
- Children under 5 years old
- Pregnant women
- People with chronic conditions (e.g., asthma, diabetes, heart disease)
- Immunocompromised individuals
Common Symptoms of Influenza
- Fever or chills
- Cough and sore throat
- Runny or stuffy nose
- Muscle or body aches
- Fatigue
- Headaches
Frequently Asked Questions
Got Questions About Flu or mRNA Vaccines?
Have a look at some of our most frequently asked questions regarding clinical trials and what they’re all about. If you can’t find the answer you’re looking for, call us at: +1 (248) 721-9539.
